Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial

By Balen Adam   Platteau Peter   Andersen Anders Nyboe   Devroey Paul   Helmgaard Lisbeth   Arce Joan-Carles  

Human Reproduction, Vol. 22, Iss. 7, 2007-07 ,pp. : 1816-1823

Oxford University Press

Access to resources Recommend Favorite

Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study

By Hugues J.N.  

Human Reproduction, Vol. 20, Iss. 3, 2005-03 ,pp. : 629-635

Oxford University Press

Access to resources Recommend Favorite

Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate

By Nyboe Andersen Anders   Balen Adam   Platteau Peter   Devroey Paul   Helmgaard Lisbeth   Arce Joan-Carles  

Human Reproduction, Vol. 23, Iss. 6, 2008-06 ,pp. : 1424-1430

Oxford University Press

Access to resources Recommend Favorite

Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open‐label, randomized, controlled trial

By Ricci G.   Cerneca F.   Simeone R.   Pozzobon C.   Guarnieri S.   Sartore A.   Pregazzi R.   Guaschino S.  

Human Reproduction, Vol. 19, Iss. 4, 2004-04 ,pp. : 838-848

Oxford University Press

Access to resources Recommend Favorite

Controlled ovarian stimulation using highly purified FSH results in a lower serum oestradiol profile in the follicular phase as compared with HMG

By Fried Gabriel   Harlin J.   Csemiczky G.   Wramsby H.  

Human Reproduction, Vol. 11, Iss. 3, 1996-03 ,pp. : 474-477

Oxford University Press

Access to resources Recommend Favorite